Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdiQure: Allogeneic Adipose-Derived MSCs for Severe COVID-19 Pneumonia
NCT04366323Phase 2Completed
- Sponsor
- Red Andaluza de Terapias Avanzadas
- Start
- Apr 2020
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CSCC_ASC in COVID-19 pneumonia, sponsored by Red Andaluza de Terapias Avanzadas. Started Apr 2020; status: completed.
02
Drugs
CSCC_ASC
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04366323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04366323.